scout
|Videos|February 21, 2023

HER2+ mBC: First-Line Treatment Regimens

A focused discussion on available options for the first-line treatment of HER2+ metastatic breast cancer (mBC), with reference to data from the CLEOPATRA trial.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME